US Patent Issued to Adaptive Biotechnologies, Fred Hutchinson Cancer Center on Sept. 30 for "Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing" (Washington Inventors)

ALEXANDRIA, Va., Sept. 30 -- United States Patent no. 12,428,682, issued on Sept. 30, was assigned to Adaptive Biotechnologies Corp. (Seattle) and Fred Hutchinson Cancer Center (Seattle).

"Methods for diagnosing infectious disease and determining HLA status using immune repertoire sequencing" was invented by Ryan O. Emerson (Seattle), Harlan S. Robins (Seattle), Mark J. Rieder (Seattle), William S. Dewitt III (Seattle) and Christopher S. Carlson (Seattle).

According to the abstract* released by the U.S. Patent & Trademark Office: "Methods are provided for predicting a subject's infection status using high-throughput T cell receptor sequencing to match the subject's TCR repertoire to a known set of disease-associated T cell receptor sequen...